Kate M O’Dell

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Rheumatoid arthritis is a chronic, progressive autoimmune disease associated with inflammation and destruction of joints and systemic effects, which result in significant impact on patient's quality of life and function. Tofacitinib was approved for the treatment of rheumatoid arthritis in the USA in 2012 and subsequently in other countries, but not by the(More)
  • 1